Hyperfine, Inc. (HYPR) vs Lucid Diagnostics Inc. (LUCD)
- Hyperfine, Inc. HYPR 0.75 −3.85%
- Lucid Diagnostics Inc. LUCD 0.48 −7.69%
Hyperfine, Inc. and Lucid Diagnostics Inc. are both Medical Devices companies. Lucid Diagnostics Inc. is the larger, with a market value of $105.7M against $82.7M — 1.3× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 24.9%. Hyperfine, Inc. has the higher net margin (−210.8% vs −1,193.9%) and the higher return on invested capital (−401.8% vs −3,096.5%). Across the 17 metrics below, Hyperfine, Inc. leads on 14 and Lucid Diagnostics Inc. on 3.
Valuation
Profitability
| Metric | HYPR | LUCD | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | (21.69%) | 56.01% |
| Operating margin | (203.27%) | (930.84%) | (15.03%) |
| Net margin | (210.75%) | (1,193.87%) | (20.40%) |
| Free cash flow margin | (166.48%) | (866.56%) | (7.24%) |
| Return on equity | (96.97%) | 364.89% | (15.32%) |
| Return on assets | (64.40%) | (167.51%) | (19.72%) |
| Return on invested capital | (401.79%) | (3,096.53%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack